Live healthier, stronger and sharper for longer
Daily longevity reporting — trending research, working protocols, and the supplements and peptides moving the needle on healthspan.
Research & NewsLongevity Research Roundup: Molecular Clues
Exercise reshapes molecular ageing, GLP-1 drugs hint at broader anti-ageing effects, and new compounds target immune and brain health in our July 2026 roundup.
Research & NewsLongevity Research Roundup: Genes, Lysosomes,
Semaglutide's anti-ageing signal, genetic clues from centenarians, and reversing stem cell ageing highlight this week's longevity news.
Research & NewsLongevity Research Roundup: Timing, Genes &
Semaglutide's anti-ageing markers, new epigenetic clocks, rapamycin's sex-biased effects, and crucial timing for interventions take centre stage this week.
Research & NewsLongevity Research Roundup: Incretins, Immunity
This week’s research brings exciting news on GLP-1s for kidney and brain health, alongside promising human trials for senolytics and novel AI drug discovery.
Research & NewsLongevity Research Roundup: Incretins, Skin,
A deep dive into recent longevity science: tirzepatide’s multifaceted benefits, GLP-1’s systemic anti-inflammatory role, novel skin rejuvenation, menopausal bladder health, and the power of subjective age.
Research & NewsLongevity Research Roundup: Metabolic Health
This month's roundup covers GLP-1 RAs, metabolic improvements, and what the latest longevity science means for your health.
Research & NewsLongevity Research Roundup: Emerging Paths to
This week, we delve into new data on GLP-1s, novel rapamycin delivery, AKG's potential atherogenic risk, and AI's increasing role in healthspan. Essential reading.
Metabolic HealthGLP-1 Drugs Beyond Weight Loss: The Longevity Signal Nobody Expected
New cardiovascular, kidney and cognitive outcome data is reframing GLP-1 receptor agonists as potential healthspan drugs, not just appetite suppressants.